Eric Lefkofsky is the co-founder of Tempus Labs based in Chicago, Illinois. He is a successful entrepreneur in his own right. Barely three years after the launch of Tempus, it has received recognition worldwide for its efforts as a healthcare startup. Tempus has partnered with the National Cancer Institute and others centers across the nation. Tempus offers a wide variety of services to cancer patients. The facilities include; cancer testing, germline DNA, RNA tumors sequencing, pathology, medical imaging, and liquid biopsy among others. Tempus has made technological advances in healthcare. This has landed it on Eric Topol’s list which features popular advances that promise to revolutionize medicine.
Tempus lab made a name for itself as one of the upcoming startups. Its use of revolutionary technology has distinguished it. It has used gene therapy and gene editing to treat ailments that were once thought terminal. Recently, Tempus developed Voretigene neparvovec-rzyl which was approved by the FDA to treat a rare form of a disease that might cause blindness. Tempus has also made advancement in skin diagnostic technology whereby it can accurately identify both malignant and benign tumors. It recently partnered with Apple to produce an ECG-apple watch that can diagnose atrial fibrillation. Tempus has also developed a pathogen sequencing device which enables physicians to come up with favorable medical responses in cases of outbreaks. It also came up with FDA approved glucose senses which can be used to dose insulin into a patient’s system directly.
Tempus has also received FDA approval for two types of drugs named Yescarta and Kymriah. Yescarta treats patients’ relapsed aggressive B-cell and Kymriah is used for pediatric and youths with refractory acute lymphoblastic leukemia.
Tempus was established in 2015.It offers extensive and analytical machine learning platform which enables physicians to provide more personalized cancer care for patients. Tempus helps physicians make calculated decisions based on real-time data generated from their genomic sequencing technology. The company aims at delivering efficient healthcare to all its cancer patients.
About Eric Lefkofsky
Lefkosky is a serial philanthropist. He has co-founded numerous tech companies such as Groupon, Uptake Technologies. He also partnered with his wife to establish the Lefkofsky Family Foundation. The foundation aims at making high impact advancements in the education, arts, culture and human rights.
For More info: www.crunchbase.com/person/eric-lefkofsky